Fosmidomycin for the Treatment of Canine Otitis Externa: A Randomised, Double‐Blinded, Controlled ‘Split Body’ Clinical Trial
Veterinary Dermatology · 2026
DOI: 10.1111/vde.70049 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary Dermatology, 2026. Verfasst von Lindsey E Citron und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences and Advanced Medicine, University of Pennsylvania, School of Veterinary Medicine, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Dog Diseases, Fosfomycin, Otitis Externa. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Pennsylvania School of Veterinary Medicine, Morris Animal Foundation.
Abstract (Originalsprache)
Background
Targeted antimicrobial therapy for canine otitis externa ( OE ) represents an opportunity for antimicrobial stewardship. Fosmidomycin selectively inhibits the non‐mevalonate pathway for isoprenoid biosynthesis utilised by canine‐adapted, and not human‐adapted, staphylococci.
Objectives
To evaluate the safety and efficacy of fosmidomycin for treatment of bacterial OE compared with enrofloxacin. Animals Fifteen client‐owned dogs with bilateral bacterial OE were enrolled. Materials and Methods Fosmidomycin stability in solution for 28 days was confirmed before trial commencement. A ‘split body’ design was used: each ear canal was randomised to receive a solution of fosmidomycin or enrofloxacin applied twice daily for 28 days, combined with a tapering anti‐inflammatory course of oral prednisone. Owners and investigators were blinded to treatments. Dogs were evaluated at Day (D)0, D14 and D28 with clinical scores (0–3 otitis index score [ OTIS3 ], ear cytological results, pain) and owner assessments (pruritus scores for each ear, quality‐of‐life scores and a hearing questionnaire). On D28 , owners and investigators assessed global treatment efficacy for each ear.
Results
Treatment group did not significantly influence clinical scores; cytological scores, OTIS3 scores and pruritus scores significantly improved for both groups over the trial period. Treatment efficacy for both ears was assessed as good‐to‐excellent by owners and investigators for the majority of dogs. No safety concerns were identified. Conclusions and Clinical Relevance Fosmidomycin and enrofloxacin performed comparably for topical treatment of bacterial otitis in this study. Fosmidomycin is a promising targeted antimicrobial for canine bacterial infections while limiting selection for antimicrobial resistance in human pathogens such as Staphylococcus aureus .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Sciences and Advanced Medicine, University of Pennsylvania, School of Veterinary Medicine, Philadelphia, Pennsylvania, USA.
- Department of Clinical Studies-New Bolton Center, School of Veterinary Medicine, University of Pennsylvania, Kennett, Pennsylvania, USA.
- Pennsylvania Equine Toxicology & Research Laboratory, West Chester, Pennsylvania, USA.
- Matthew J. Ryan Veterinary Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
ORCID-Profile: Lindsey E Citron, Darko Stefanovski, Youwen You, Rachel Proctor, Julie Randall, Christine L Cain
Förderung
- University of Pennsylvania School of Veterinary Medicine
- Morris Animal Foundation
Zitieren
APA
Citron, L. E., Stefanovski, D., You, Y., Proctor, R., Watson, D., Randall, J., & Cain, C. L. (2026). Fosmidomycin for the Treatment of Canine Otitis Externa: A Randomised, Double‐Blinded, Controlled ‘Split Body’ Clinical Trial. Veterinary Dermatology. https://doi.org/10.1111/vde.70049
Vancouver
Citron LE, Stefanovski D, You Y, Proctor R, Watson D, Randall J, et al. Fosmidomycin for the Treatment of Canine Otitis Externa: A Randomised, Double‐Blinded, Controlled ‘Split Body’ Clinical Trial. Veterinary Dermatology. 2026. doi:10.1111/vde.70049
BibTeX
@article{Citron2026,
author = {Citron, Lindsey E and Stefanovski, Darko and You, Youwen and Proctor, Rachel and Watson, Donna and Randall, Julie and Cain, Christine L},
title = {Fosmidomycin for the Treatment of Canine Otitis Externa: A Randomised, Double‐Blinded, Controlled ‘Split Body’ Clinical Trial},
journal = {Veterinary Dermatology},
year = {2026},
doi = {10.1111/vde.70049}
}
EUVIMED